S 81694 Plus Paclitaxel in Metastatic Breast Cancer

NCT03411161 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Breast Cancer
Metastatic Triple Negative Breast Cancer

Interventions

DRUG: Combination therapy (S81694 + paclitaxel) phase I
DRUG: Paclitaxel
DRUG: Combination therapy (S81694 + paclitaxel) phase II

Sponsor

Institut de Recherches Internationales Servier

Collaborators

[object Object]